419 related articles for article (PubMed ID: 31644910)
61. In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma.
Sezer A; Mahmutović L; Akçeşme B
Med Oncol; 2023 Dec; 41(1):37. PubMed ID: 38155268
[TBL] [Abstract][Full Text] [Related]
62. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.
Gross O; Grupp C; Steinberg C; Zimmermann S; Strasser D; Hannesschläger N; Reindl W; Jonsson H; Huo H; Littman DR; Peschel C; Yokoyama WM; Krug A; Ruland J
Blood; 2008 Sep; 112(6):2421-8. PubMed ID: 18192506
[TBL] [Abstract][Full Text] [Related]
63. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
[TBL] [Abstract][Full Text] [Related]
64. T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.
Hamilton KS; Phong B; Corey C; Cheng J; Gorentla B; Zhong X; Shiva S; Kane LP
Sci Signal; 2014 Jun; 7(329):ra55. PubMed ID: 24917592
[TBL] [Abstract][Full Text] [Related]
65. The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease.
Schaefer BC
Cell Immunol; 2020 Oct; 356():104189. PubMed ID: 32771677
[No Abstract] [Full Text] [Related]
66. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1.
Wang D; Matsumoto R; You Y; Che T; Lin XY; Gaffen SL; Lin X
Mol Cell Biol; 2004 Jan; 24(1):164-71. PubMed ID: 14673152
[TBL] [Abstract][Full Text] [Related]
67. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
[TBL] [Abstract][Full Text] [Related]
68. MALT1 substrate cleavage: what is it good for?
Moud BN; Ober F; O'Neill TJ; Krappmann D
Front Immunol; 2024; 15():1412347. PubMed ID: 38863711
[TBL] [Abstract][Full Text] [Related]
69. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
[TBL] [Abstract][Full Text] [Related]
70. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
[TBL] [Abstract][Full Text] [Related]
71. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
Afonina IS; Elton L; Carpentier I; Beyaert R
FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
[TBL] [Abstract][Full Text] [Related]
72. Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas.
Eitelhuber AC; Vosyka O; Nagel D; Bognar M; Lenze D; Lammens K; Schlauderer F; Hlahla D; Hopfner KP; Lenz G; Hummel M; Verhelst SH; Krappmann D
Chem Biol; 2015 Jan; 22(1):129-38. PubMed ID: 25556945
[TBL] [Abstract][Full Text] [Related]
73. Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome.
Meininger I; Krappmann D
Biol Chem; 2016 Dec; 397(12):1315-1333. PubMed ID: 27420898
[TBL] [Abstract][Full Text] [Related]
74. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.
Wegener E; Oeckinghaus A; Papadopoulou N; Lavitas L; Schmidt-Supprian M; Ferch U; Mak TW; Ruland J; Heissmeyer V; Krappmann D
Mol Cell; 2006 Jul; 23(1):13-23. PubMed ID: 16818229
[TBL] [Abstract][Full Text] [Related]
75. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.
Chan W; Schaffer TB; Pomerantz JL
Mol Cell Biol; 2013 Jan; 33(2):429-43. PubMed ID: 23149938
[TBL] [Abstract][Full Text] [Related]
76. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
Fontán L; Melnick A
Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
[TBL] [Abstract][Full Text] [Related]
77. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
McAllister-Lucas LM; Jin X; Gu S; Siu K; McDonnell S; Ruland J; Delekta PC; Van Beek M; Lucas PC
J Biol Chem; 2010 Aug; 285(34):25880-4. PubMed ID: 20605784
[TBL] [Abstract][Full Text] [Related]
78. MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
Minderman M; Lantermans HC; Grüneberg LJ; Cillessen SAGM; Bende RJ; van Noesel CJM; Kersten MJ; Pals ST; Spaargaren M
Blood Cancer J; 2023 Mar; 13(1):37. PubMed ID: 36922488
[TBL] [Abstract][Full Text] [Related]
79. Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma.
Thys A; Douanne T; Bidère N
Front Oncol; 2018; 8():498. PubMed ID: 30474008
[TBL] [Abstract][Full Text] [Related]
80. NF-kappaB activation in T cells requires discrete control of IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation and IKKgamma ubiquitination by the ADAP adapter protein.
Srivastava R; Burbach BJ; Shimizu Y
J Biol Chem; 2010 Apr; 285(15):11100-5. PubMed ID: 20164171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
